Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy

被引：0
作者：
Lan-Lan Pang
Jia-Di Gan
Yi-Hua Huang
Jun Liao
Wei-Tao Zhuang
Wael-Abdullah-Sultan Ali
Shao-Dong Hong
Li Zhang
Wen-Feng Fang
机构：
[1] Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
来源：
BMC Cancer | / 23卷
关键词：
Non-small cell lung cancer; Immunotherapy; Chemotherapy; Combination; Antiangiogenic agents; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC [J].
Andric, Zoran ;
Galffy, Gabriella ;
Dols, Manuel Cobo ;
Szima, Barna ;
Stojanovic, Goran ;
Petrovic, Marina ;
Felip, Enriqueta ;
Baz, David Vicente ;
Aix, Santiago Ponce ;
Juan-Vidal, Oscar ;
Szalai, Zsuzsanna ;
Losonczy, Gyorgy ;
Blanco, Antonio Calles ;
Bernabe, Reyes ;
Ledo, Gema Garcia ;
Hernandez, Andres Aguilar ;
Duecker, Klaus ;
Zhou, Dongli ;
Schroeder, Andreas ;
Guezel, Guelseren ;
Ciardiello, Fortunato .
JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (02)
[32]   Efficacy of crizotinib in first-line treatment of adults with ALK-positive advanced NSCLC [J].
Zhang, Yi-chen ;
Zhou, Qing ;
Wu, Yi-Long .
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (12) :1693-1701
[33]   The role of nivolumab combined to immunotherapy and/or chemotherapy in the first-line treatment of advanced Non Small Cell Lung Cancer [J].
Rocco, Danilo ;
Della Gravara, Luigi ;
Battiloro, Ciro ;
Gridelli, Cesare .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (03) :303-309
[34]   The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis [J].
Kim, Bum Jun ;
Kim, Jung Han ;
Jang, Hyun Joo ;
Kim, Hyeong Su .
ONCOTARGET, 2017, 8 (58) :99033-99040
[35]   Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysis [J].
Petrelli, Fausto ;
Ferrara, Roberto ;
Signorelli, Diego ;
Ghidini, Antonio ;
Proto, Claudia ;
Roudi, Raheleh ;
Sabet, Mehrdad N. ;
Facelli, Sara ;
Garassino, Marina C. ;
Luciani, Andrea ;
Roviello, Giandomenico .
IMMUNOTHERAPY, 2021, 13 (07) :621-632
[36]   Tyrosine kinase inhibitors as first-line treatment in NSCLC [J].
Maemondo, Makoto .
LANCET ONCOLOGY, 2016, 17 (05) :541-543
[37]   Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC [J].
Socinski, M. A. ;
Jotte, R. M. ;
Cappuzzo, F. ;
Orlandi, F. ;
Stroyakovskiy, D. ;
Nogami, N. ;
Rodriguez-Abreu, D. ;
Moro-Sibilot, D. ;
Thomas, C. A. ;
Barlesi, F. ;
Finley, G. ;
Kelsch, C. ;
Lee, A. ;
Coleman, S. ;
Deng, Y. ;
Shen, Y. ;
Kowanetz, M. ;
Lopez-Chavez, A. ;
Sandler, A. ;
Reck, M. ;
Ahualli, A. ;
Jarchum, G. ;
Kaen, D. L. ;
Kahl, S. ;
Kotliar, M. ;
Kowalyszyn, R. D. ;
Lerzo, G. ;
Magri, I ;
Martin, C. ;
Pastor, A. ;
Picon, P. ;
Streich, G. ;
Varela, M. ;
Blinman, P. ;
Boyer, M. ;
Crombie, C. ;
Gauden, S. ;
Gill, S. ;
Hughes, B. ;
John, T. ;
Joshi, A. ;
Kosmider, S. ;
Lewis, C. ;
Millward, M. ;
Nordman, I ;
Nott, L. ;
O'Byrne, K. ;
Parnis, F. ;
Potasz, N. ;
Richardson, G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (24) :2288-2301
[38]   Cost-effectiveness analysis of nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced NSCLC [J].
Li, Jiahao ;
Zhang, Tiantian ;
Xu, Yongmei ;
Lu, Peiyao ;
Zhu, Jiaxin ;
Liang, Wenhua ;
Jiang, Jie .
IMMUNOTHERAPY, 2020, 12 (14) :1067-1075
[39]   Potential Treatment Options After First-Line Chemotherapy for Advanced NSCLC: Maintenance Treatment or Early Second-Line? [J].
Gridelli, Cesare ;
Maione, Paolo ;
Rossi, Antonio ;
Ferrara, Marianna Luciana ;
Bareschino, Maria Anna ;
Schettino, Clorinda ;
Sacco, Paola Claudia ;
Ciardiello, Fortunato .
ONCOLOGIST, 2009, 14 (02) :137-147
[40]   Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients [J].
Saint-Jean, Melanie ;
Fronteau, Clementine ;
Peuvrel, Lucie ;
Khammari, Amir ;
Varey, Emilie ;
Quereux, Gaelle ;
Dreno, Brigitte .
MEDICINE, 2020, 99 (29) :E21329
12345